Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06142292 · ClinicalTrials.gov registry record · NA
Mitigating Mental and Social Health Outcomes of COVID-19: a Counseling Approach
A NA study, sponsored by Idaho State University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT06142292: Completed NA study, sponsored by Idaho State University.
NCT06142292 is a NA study that has completed, run by Idaho State University. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06142292, a NA study, has completed, sponsored by Idaho State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to develop a comprehensive mental health counseling program purposed to address the social determinant of health impacts of the coronavirus disease of 2019 (COVID-19). The main questions the investigators aim to answer are: 1) What are the mental and social determinant of health impacts of a COVID-19 diagnosis, and 2) What are the impacts of a counseling program implemented to address those impacts? Participants will participate in individual interviews, attend individual and group counseling, and be provided resources related to their social determinants of health needs.
Primary Outcome
Semi-structured, audio recorded interview to gather information on the SDOH and mental health impacts of COVID-19
Interventions
- BEHAVIORAL Individual counseling
- BEHAVIORAL Group counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2024-04-16 |
| Est. Completion | 2025-02-21 |
| Phase | NA |
What the finished NCT06142292 record still lists
NCT06142292 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Individual counseling is the first listed.
NCT06142292 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06142292 about?
NCT06142292 is a clinical study titled "Mitigating Mental and Social Health Outcomes of COVID-19: a Counseling Approach". The goal of this clinical trial is to develop a comprehensive mental health counseling program purposed to address the social determinant of health impacts of the coronavirus disease of 2019 (COVID-19). The main questions the investigators aim to answer are: 1) What are the mental and social determi...
What is the current status of trial NCT06142292?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2024-04-16. Estimated completion is 2025-02-21.
What interventions are being tested in trial NCT06142292?
The interventions under investigation include: Individual counseling (BEHAVIORAL), Group counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT06142292?
This trial is sponsored by Idaho State University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06142292's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI